Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02167464 · ClinicalTrials.gov registry record · NA
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
A NA study of Hypertension, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 8
- Study locations
NCT02167464: Completed NA study of Hypertension, sponsored by Medical University of South Carolina.
NCT02167464 is a NA study of Hypertension that has completed, run by Medical University of South Carolina. The registered enrollment target is 70 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 8 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02167464, a NA study of Hypertension, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 8
- Study locations
Study Summary
Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Therapeutics, and combination of Hypertension Specialist and Renin Treatment-Guided Therapeutics. Patients with TRH are evaluated with the BpTRU device for an accurate and representative blood pressure measure on two occasions before entry into the study. Qualitative data from focus group discussions with practice staff, and patient surveys and interviews will provide contextual data to help explain why some interventions are more acceptable and successful than others.
Primary Outcome
Blood pressure control will be assessed according to guidelines established by American Heart Association.
Conditions Studied
Interventions
- DRUG Renin treatment-guided Therapeutics
- OTHER Referral Hypertension specialist
- DRUG Aldosterone Antagonist
Study Locations (8)
South Carolina
- AnMed - Anderson
- Beaufort Jasper Hampton Comprehensive Health - Beaufort
- McLeod Family Medicine Center - Florence
- Family Diagnostics - Holly Hill
- Lovelace Family Medicine - Prosperity
- Carolina Medical Affiliates - Spartanburg
- Spartanburg Regional Health Services - Spartanburg
- Palmetto Primary Care - Summerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2011-06 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT02167464 record still lists
NCT02167464 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Renin treatment-guided Therapeutics is the first listed.
NCT02167464 lists 8 locations in 1 state (South Carolina).
Frequently Asked Questions
What is clinical trial NCT02167464 about?
NCT02167464 is a clinical study titled "Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study". Comparative Effectiveness Research using an intent-to-treat approach in 8 clinics in South Carolina. The investigators will assess 4 efficacious approaches to controlling treatment-resistant hypertension (TRH): Aldosterone Antagonist, Referral to Hypertension Specialist, Renin Treatment-Guided Thera...
What is the current status of trial NCT02167464?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2011-06. Estimated completion is 2015-01.
What conditions does trial NCT02167464 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT02167464?
The interventions under investigation include: Renin treatment-guided Therapeutics (DRUG), Referral Hypertension specialist (OTHER), Aldosterone Antagonist (DRUG).
Who is sponsoring clinical trial NCT02167464?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02167464 being conducted?
This trial has 8 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02167464's enrollment target sits among peer trials
70 334th of 470 higher than 133 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia